Sep 22, 2008 by Brian Orelli, PhDLet's Bail Out Pharma NextSchering is cutting jobs. Maybe the government should help out?
Sep 22, 2008 by Brian Orelli, PhDOuch, That's Gotta Hurt!Acupuncture beats Wyeth's Effexor in stopping hot flashes.
Sep 19, 2008 by Brian Orelli, PhDSkinning the CompetitionJ&J's psoriasis drug candidate beats Amgen and Wyeth's Enbrel.
Sep 18, 2008 by Brian Orelli, PhDRanbaxy's Troubles Won't Help CompetitorsIt may be hard to get a hit in with so much competition kicking Ranbaxy while it's down.
Sep 18, 2008 by Brian Orelli, PhDMedical Device Makers Throwing Money Down the TubeCongress is investigating medical device maker's direct-to-consumer ads.
Sep 17, 2008 by Brian Orelli, PhDMonsanto's Guidance Keeps GrowingLike a pesticide-resistant weed, baby.
Sep 17, 2008 by Brian Orelli, PhDIPO? In This Market?Bristol-Myers continues with plans to spin off its nutritionals business.
Sep 17, 2008 by Brian Orelli, PhDWill Denosumab Strengthen Amgen's Bones?The data might not be strong enough in the competitive market.
Sep 16, 2008 by Brian Orelli, PhDIs Pharma Still a Safe Investment?Judging by Monday, it doesn't seem like it. But is that really true?
Sep 15, 2008 by Brian Orelli, PhDAre Health Insurers Losing Their Pricing Power?Can they pass costs on to their customers?
Sep 15, 2008 by Brian Orelli, PhDThe Little Label Expansion That Couldn'tMerck gets Gardasil approved to protect against other cancers.
Sep 15, 2008 by Brian Orelli, PhDTeva and FDA's Never-Ending Court BattleTeva looses latest battle against the FDA.
Sep 15, 2008 by Brian Orelli, PhDSide Effects Don't Scare IcahnThe billionaire takes a larger stake in Amylin.
Sep 12, 2008 by Brian Orelli, PhDMonsanto Makes Half a DiscoveryIt's raising corn production a little at a time.
Sep 12, 2008 by Brian Orelli, PhDAffymetrix Astounds, in the Worst WayAnother poor quarter from the biochip maker.
Sep 11, 2008 by Brian Orelli, PhDVive le Vioxx LawsuitMerck's shareholders get their case reinstated.
Sep 11, 2008 by Brian Orelli, PhDGlaxo's Not GamblingThe pharmaceutical's deal for a drug developer is back-end loaded.
Sep 11, 2008 by Brian Orelli, PhDCEO Writes a Big Check for a Big MistakeUnitedHealth's former CEO has to pay for his backdating mistakes.
Sep 10, 2008 by Brian Orelli, PhDAre Drug Companies Being Shortsighted With R&D?Cutting research and development spending is playing with fire.
